Navigation Links


VIT in Medical Products

IGFBP-2 RIA Test

Description:...also been identified in other body fluids such as cerebrospinal [4], amniotic and coelomic fluids [5], urine [6] and seminal fluid [7]. Rechler M. vit Horm 47:1-114, 1993. Delhanty PJD & Han VKM. Endocrinology 132:41-52, 1993. Juul A, et al. J Clin Endocrinol Metab 78: 744-52, 1994. Muller HL, ...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-2 ELISA Test

Description:...also been identified in other body fluids such as cerebrospinal [4], amniotic and coelomic fluids [5], urine [6] and seminal fluid [7]. Rechler M. vit Horm 47:1-114, 1993. Delhanty PJD & Han VKM. Endocrinology 132:41-52, 1993. Juul A, et al. J Clin Endocrinol Metab 78: 744-52, 1994. Muller HL, ...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, w/ Extraction IRMA Test

Description:...n 139:501-508, 1986. Gluckman PD & Ambler GR. Mol Cell Endocrinol 92:C1-C3, 1993 Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfeld RG, et al. J. Pediatr 109:428-433, 1986. Baxter R & Martin...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, w/ Extraction ELISA Test

Description:...n 139:501-508, 1986. Gluckman PD & Ambler GR. Mol Cell Endocrinol 92:C1-C3, 1993 Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfeld RG, et al. J. Pediatr 109:428-433, 1986. Baxter R & Martin...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, Non-Extraction IRMA Test

Description:...n 139:501-508, 1986. Gluckman PD & Ambler GR. Mol Cell Endocrinol 92:C1-C3, 1993 Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfeld RG, et al. J. Pediatr 109:428-433, 1986. Baxter R & Martin...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, Non-Extraction ELISA Test

Description:...n 139:501-508, 1986. Gluckman PD & Ambler GR. Mol Cell Endocrinol 92:C1-C3, 1993 Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfeld RG, et al. J. Pediatr 109:428-433, 1986. Baxter R & Martin...
Company:Diagnostic Systems Laboratories, Inc.

Free IGF-I IRMA Test

Description:... growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Juul A. et al. J Clin Endocrinol Metab 82: 2497-2502, 1997. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfel...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (With Extraction)

Description:... growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Juul A. et al. J Clin Endocrinol Metab 82: 2497-2502, 1997. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfel...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (With Extraction)

Description:... growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Juul A. et al. J Clin Endocrinol Metab 82: 2497-2502, 1997. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfel...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (Non-Extraction)

Description:... growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. vit Horm 47:1-114, 1993. Juul A. et al. J Clin Endocrinol Metab 82: 2497-2502, 1997. Lee PDK & Rosenfeld RG. Pediatrician 14:154-161, 1987. Rosenfel...
Company:Diagnostic Systems Laboratories, Inc.

More>>

Other Tagsassistsforecastherbherbherb
(Date:11/27/2009)...., Nov. 27 GSI Group Inc...of precision technology products and semiconductor...f the Company,s shareholders has been scheduled fo...f the meeting will be announced in due course. As...isition notice from Stephen Bershad, a holder of g...
(Date:11/27/2009)...Biotech firm Replikins Ltd. today issued its lates...ata. It shows that the lethality of the virus has...e virus,s current outbreak in the spring of 2009 t...d. 0.1). The H1N1 infectivity count, however, rema...PRWEB) November 27, 2009 -- Biotech firm Replikins...
(Date:11/27/2009)...Nov. 27 The Gymboree Cor...bert, CFO/COO, will present at the NASDAQ OMX 23rd...air Hotel in London, England, on Wednesday, Decemb...a live broadcast of The Gymboree Corporation,s pre...gymboree.com, click on "Our Company" at the bottom...
(Date:11/27/2009)...SEINE, France, Nov. 27 Team Garmin...ng team dedicated to ethical sporting and developi...nced today that it will become Team Garmin-Transit... new sponsor of the team. Transitions Optical is t...r, offering the most advanced photochromic technol...
(Date:11/27/2009)...XenaCare Holdings has announced that it has become...ne of the largest nonprofit organizations dedicate...n. , Delray Beach, FL (Vo...(OTCBB: XCHO), a company specializing in the marke...e products, has announced today that is has become...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
(Date:11/24/2009)...e crystallised a protein that may help gut bacteri...could be used by probiotic producers to identify s...ople. , "Probiotics need to interact with cells l...they attach to surfaces in the gut they are more l...ctivity," says Dr Nathalie Juge from the Institute...
(Date:11/24/2009)...he American College of Medical Toxicology (ACMT) h...ication of the Journal of Medical Toxicology (JM... March 2010. It was previously published by the U... of Medical Toxicology , an international, peer-re...nce and practice of medical toxicology. The quart...
(Date:11/24/2009)...tes fish food is a matter of debate. A high-profil...most 50 percent of their carbon from trees and lea...rrestrial and aquatic ecosystems. , But new rese...is not likely to be true. Algae provide a much ric...g to research published this week in the Proceedi...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 1Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3
Other Contentsichthyosisidiopathicidiopathicidiopathicidiopathicileushemolytichemolytichemolyticimmunizationsimmunizationsimmunizationsimmunofluorescenceimmunofluorescenceimmunofluorescenceimmunofluorescence